Berkeley, CA, United States
Valor Compounding Pharmacy, Inc DBA Valor Compounding Pharmacy recalls
2 recalls recorded since 2018, most recently on 27 June 2022. None are listed as ongoing. Status and classification are as published by the FDA.
Recalls2
Ongoing (FDA)0
Terminated or completed2
Class I (FDA)2
Terminated Class I Drugs
- Recall started
- 27 June 2022
- Terminated
- 28 September 2022
- Reason
- Subpotent and Superpotent Drug
- Distribution
- CA only
- Initiated
- Voluntary: Firm initiated
- Recall number
- D-1286-2022
- Nifedipine WSP 0.2% Ointment, 60 gram tubes, Rx only, Valor Compounding Pharmacy, 2461 Shattuck Ave., Berkeley, CA 94704
Terminated Class I Drugs
- Recall started
- 15 April 2022
- Terminated
- 7 November 2022
- Reason
- Subpotent drug
- Distribution
- CA
- Initiated
- Voluntary: Firm initiated
- Recall numbers
- D-1167-2022, D-1168-2022
- Tacrolimus (Brand Capsules ) 0.5 mg/mL Suspension, Rx, This is a compounded medication., Valor Compounding Pharmacy, 2461 Shattuck Ave., Berkeley, CA 94704,
- Tacrolimus (Brand Capsules ) 0.5 mg/mL Suspension, Rx, This is a compounded medication., Valor Compounding Pharmacy, 2461 Shattuck Ave., Berkeley, CA 94704
A terminated FDA recall means the FDA has determined that all reasonable efforts to remove or correct the product have been made. What statuses mean.